Citation Impact
Citing Papers
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
2003 StandoutNobel
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
2012
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
2008
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer
2018
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Combinatorial Cancer Immunotherapy
2006
Inflammation and cancer
2002 StandoutNature
Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients
2006
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
2007
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Angiogenesis in cancer and other diseases
2000 StandoutNature
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
2002 Standout
Immunology and immunotherapy of colorectal cancer
2003
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Immune surveillance of tumors
2007
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
TRP channels as cellular sensors
2003 StandoutNature
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
2011
Immunity, Inflammation, and Cancer
2010 Standout
Cytokines in cancer pathogenesis and cancer therapy
2004
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
1996 Standout
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
1997
Cytokine-secreting tumor cell vaccines
2000
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer
1993
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Clonal evolution in cancer
2012 StandoutNature
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Treatment of Breast Cancer
1998
Cancer-related inflammation
2008 StandoutNature
The biologic importance of tumor‐infiltrating lymphocytes
2010
Angiogenesis as a therapeutic target
2005 StandoutNature
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
1996
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
The Three Es of Cancer Immunoediting
2004 Standout
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
1997 StandoutScience
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
2003
Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.
1998
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
2003
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
2005
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Deep Learning—A Technology With the Potential to Transform Health Care
2018 StandoutNobel
Overall survival and PD‐L1 expression in metastasized malignant melanoma
2010
Neoantigens in cancer immunotherapy
2015 StandoutScience
Vitamin B12and folate in relation to the development of Alzheimer’s disease
2001
Computer Aided Diagnostic Support System for Skin Cancer: A Review of Techniques and Algorithms
2013
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Immune recognition and tumor protection
2002
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of D. Schultz being referenced
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
1989 Standout
Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.
1996
The Significance of Subnormal Serum Vitamin B 12 Concentration in Older People: A Case Control Study
1996
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1999